Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
CACNA2D3 55799 IMAGABALIN CHEMBL2103836 modulator ChemblInteractions
CACNA2D3 55799 PREGABALIN CHEMBL1059 modulator ChemblInteractions
CACNA2D3 55799 ATAGABALIN CHEMBL593430 modulator ChemblInteractions
CACNA2D3 55799 BEPRIDIL HYDROCHLORIDE CHEMBL1200382 blocker ChemblInteractions
CACNA2D3 55799 GABAPENTIN ENACARBIL CHEMBL1628502 modulator ChemblInteractions
CACNA2D3 55799 CELECOXIB CHEMBL118 PharmGKB
CACNA2D3 55799 NILVADIPINE CHEMBL517427 inhibitor DrugBank 11426839, 19634509, 20097194, 10525060, 10374627, 9249249
CACNA2D3 55799 GABAPENTIN CHEMBL940 modulator ChemblInteractions

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
CACNA2D3 rs4505744 AA antipsychotics efficacy yes Patients with the AA genotype had a greater decrease in Positive and Negative Syndrome Scale (PANSS)-negative scores over a period of 12 months as compared to those with the GG genotype. No significant association was seen when comparing the AG vs GG genotype. Significance was set at p<3.45E-6. Please note that alleles have been complemented to the plus chromosomal strand. Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype GG. 30032160 1449753292
CACNA2D3 rs7427395 CC antipsychotics efficacy yes Patients with the CC genotype had a greater decrease in Positive and Negative Syndrome Scale (PANSS)-general scores over a period of 12 months as compared to those with the TT genotype. No significant association was seen when comparing the CT vs CC genotype. Significance was set at p<3.45E-6. Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype TT. 30032160 1449753400